Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2024-10-30 00:00:00 ET · period of report 2024-10-28 · accession 0000950170-24-119051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-10-30 | 2024-10-28+ | GLUE | Versant Venture Capital VI, L.P. | 10% | S - Sale | $9.44 | -157.9K | 1.59M | -9% | -$1.49M |
| 2024-10-30 | 2024-10-28 | GLUE | Versant Venture Capital VI, L.P. | 10% | J - Other | $0.00 | -1.02M | 4.08M | -20% | $0 | |
| MI | 2024-10-30 | 2024-10-28 | GLUE | Versant Venture Capital VI, L.P. | 10% | J - Other | $0.00 | -366.6K | 1.64M | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-28 | S | D | 89,990 | $9.66 | 2,007,948 | I See Footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.50 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. (F2) Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. |
| 2 | Common | Common Stock | 2024-10-28 | J | D | 1,019,867 | $0.00 | 4,079,469 | D See Footnote | — | — | (F4) Shares held by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Versant Ventures VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. (F6) Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. |
| 3 | Common | Common Stock | 2024-10-28 | J | A | 20,397 | $0.00 | 20,397 | I See Footnote | — | — | (F6) Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. |
| 4 | Common | Common Stock | 2024-10-28 | J | D | 20,397 | $0.00 | 0 | I See Footnote | — | — | (F9) Shares held by Versant Ventures VI GP-GP. |
| 5 | Common | Common Stock | 2024-10-28 | J | A | 17,595 | $0.00 | 17,595 | I See Footnote | — | — | (F9) Shares held by Versant Ventures VI GP-GP. |
| 6 | Common | Common Stock | 2024-10-28 | J | D | 17,595 | $0.00 | 0 | I See Footnote | — | — | (F2) Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. |
| 7 | Common | Common Stock | 2024-10-29 | S | D | 15,600 | $9.41 | 1,573,453 | I | — | — | (F19) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.33 to $9.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (19) to this Form 4. |
| 8 | Common | Common Stock | 2024-10-28 | J | A | 5,499 | $0.00 | 5,499 | I See Footnote | — | — | (F13) Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. |
| 9 | Common | Common Stock | 2024-10-28 | J | D | 5,499 | $0.00 | 0 | I See Footnote | — | — | (F16) Shares held by Versant Vantage I GP-GP. |
| 10 | Common | Common Stock | 2024-10-28 | J | A | 5,454 | $0.00 | 5,454 | I See Footnote | — | — | (F16) Shares held by Versant Vantage I GP-GP. |
| 11 | Common | Common Stock | 2024-10-28 | J | D | 5,454 | $0.00 | 0 | I See Footnote | — | — | (F2) Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. |
| 12 | Common | Common Stock | 2024-10-29 | S | D | 52,305 | $9.08 | 1,589,053 | I See Footnote | — | — | (F18) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.36 to $9.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (18) to this Form 4. (F2) Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. |
| 13 | Common | Common Stock | 2024-10-28 | J | D | 366,590 | $0.00 | 1,641,358 | I See Footnote | — | — | (F13) Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. |